0.9% Sodium Chloride Injection as Placebo
Sponsors
Tufts Medical Center, ScinnoHub Pharmaceutical Co., Ltd., Shanghai Ark Biopharmaceutical Co., Ltd., Beijing Tsinghua Chang Gung Hospital
Conditions
Healthy ParticipantsHealthy Subjects (HS)NephrolithiasisOsteoarthritis (OA) of the KneePostoperative Pain
Phase 1
Evaluation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BT-114143 Injection in Healthy Subjects
CompletedNCT07169240
Start: 2023-02-06End: 2025-08-02Updated: 2025-09-11
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AK0406 Injection in Healthy Adult Participants
Not yet recruitingNCT07432698
Start: 2026-02-01End: 2027-04-01Target: 32Updated: 2026-02-25
Phase 4
Effect of Steroid Injections in a Knee With Osteoarthritis
CompletedNCT01230424
Start: 2011-03-31End: 2015-01-31Updated: 2017-07-31
A Randomized, Double-Blind, Placebo-Controlled Trial of Anrikefon for Postoperative Analgesia After Percutaneous Nephrolithotomy
Not yet recruitingNCT07825142
Start: 2026-10-12End: 2029-12-30Target: 160Updated: 2026-09-17